J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF System.